1 / 22

Discovery of Neuro-regenerative Natural Products from Marine Algae and Cyanobacteria

Discovery of Neuro-regenerative Natural Products from Marine Algae and Cyanobacteria. Amanda Cordes, Dr. Doug Goeger, Dr. William Gerwick. Background. At present, there are an estimated 243,000 people living with spinal cord injuries in the United States

andres
Download Presentation

Discovery of Neuro-regenerative Natural Products from Marine Algae and Cyanobacteria

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Discovery of Neuro-regenerative Natural Products from Marine Algae and Cyanobacteria Amanda Cordes, Dr. Doug Goeger, Dr. William Gerwick

  2. Background • At present, there are an estimated 243,000 people living with spinal cord injuries in the United States • 53% of new injuries occur within the 16-30 age group

  3. Goals • Identify a small molecule from algae/cyanobacteria which exhibits activity in stimulating nerve regeneration

  4. Many algae compounds are similar to retinoic acid and eicosanoids • A marine sponge compound, Lembehyne A, promotes neurite outgrowth • Known outgrowth promoters stop cell cycle progression, as do many of the lab’s characterized compounds

  5. First – Defining Some Terms • Neuro 2a Neuroblastoma Cells: A mouse cancer cell line deriving from neurons • Neuron: Cell with capability of transmitting electric signals, found in nervous system • Neurite: Long, branching outgrowth from a neuron • Differentiate: Cells mature, adopt distinctive functions, less likely to divide http://cancerweb.ncl.ac.uk

  6. Neuro 2a Cells with Neurites

  7. Experimental Protocol • Neuro 2a cells are cultured in serum supplemented medium • Cells then exposed to novel marine extracts, observed in 24 hr increments • Neurite outgrowth compared against untreated control cells and ones treated with Lactacystin and with 8-Br-cAMP, known outgrowth promoters

  8. Neurite Outgrowth Controls Treated Control

  9. Choosing a Concentration Concentration (μg/ml) 1454 Fraction Values are % lethality

  10. 52 pure compounds • 27 crude fractions • One worth mentioning…..

  11. …Symploca www.sitesatlas.com

  12. Symploca 1454 Fractions • 1454 A • 30 μg/mL: 0.53% • 10 μg/mL: 0.27% • 1454 B • 30 μg/mL: .32% • 10 μg/mL: 1.2% • 1454 C • 30 μg/mL: Toxic • 10 μg/mL: .35%

  13. Cont’d • 1454 D • 1 μg/mL: 0.55% • 0.3 μg/mL: 1.5% • 1454 E • 10 μg/mL: 1.9% • 3 μg/mL: .88% • 1454 F • 3 μg/mL: 4.0% • 1 μg/mL: .48%

  14. Cont’d • 1454 G • 1 μg/mL: 3.1% • 0.3 μg/mL: 4.0% • 1454 H • 0.3 μg/mL: 5.2% • 0.1 μg/mL: 0.9% • 1454 I • 0.3 μg/mL: 3.2% • 0.1 μg/mL: 1.5%

  15. Sub fractions • H-1 • 0.003 μg/mL: 4.5% • 0.001 μg/mL: 0.8% • H-2 • 0.1 μg/mL: 1.1% • 0.03 μg/mL: 1.0%

  16. H-1 Peak Baseline 1 Baseline 2

  17. Assay Results • H-1 Peak • 0.03 μg/mL: 1.0% • 0.01 μg/mL: 1.6% • Baseline 1 • 0.003 μg/mL: 1.8% • 0.001 μg/mL: 0.5% • Baseline 2 • 0.003 μg/mL: 2.0% • 0.001 μg/mL: 0.6%

  18. Possible Synergisms? 0.03 μg/mL 0.003 μg/mL 0.03 μg/mL 0.003 μg/mL

  19. …..perhaps…. • H-1 Peak and Baseline 1 • 2.3% • H-1 Peak and Baseline 2 • 4.3% • 6.5% • 4.3%

  20. …..results, conclusions, and future plans… • Further investigation of Symploca compounds • Continued screening of crude fractions and newly purified compounds

  21. Acknowledgements • Rebecca Medina • Gerwick Lab • Kevin Ahern & HHMI

  22. References • Blanco et al., Cell Biol. Int. 2001, 25, 909 • Fenteany et al., J. Biol. Chem.1998, 273, 8545 • Aoki et al., Biochem. Biophys. Res. Com. 2001, 289, 558

More Related